The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance

被引：731

作者：

Robson S.C. ^{[1
]}

Sévigny J. ^{[2
]}

Zimmermann H. ^{[3
]}

机构：

[1] Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

[2] Centre de Recherche en Rhumatologie et Immunologie, Université Laval, Québec, QC

[3] Institut fuer Zellbiologie und Neurowissenschaft, Biozentrum der J.W. Goethe-Universitaet, Frankfurt am Main D-60439

来源：

Purinergic Signalling | 2006年 / 2卷 / 2期

基金：

美国国家卫生研究院; 加拿大健康研究院;

关键词：

Apyrase; Brain; CD39; Ecto-ATPase; Immunology; Ischemia; Kidney; Liver; Nervous tissue; NTPDase; Platelet; Vasculature;

D O I：

10.1007/s11302-006-9003-5

中图分类号：

学科分类号：

摘要：

Ectonucleotidases are ectoenzymes that hydrolyze extracellular nucleotides to the respective nucleosides. Within the past decade, ectonucleotidases belonging to several enzyme families have been discovered, cloned and characterized. In this article, we specifically address the cell surface-located members of the ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase/CD39) family (NTPDase1,2,3, and 8). The molecular identification of individual NTPDase subtypes, genetic engineering, mutational analyses, and the generation of subtype-specific antibodies have resulted in considerable insights into enzyme structure and function. These advances also allow definition of physiological and patho-physiological implications of NTPDases in a considerable variety of tissues. Biological actions of NTPDases are a consequence (at least in part) of the regulated phosphohydrolytic activity on extracellular nucleotides and consequent effects on P2-receptor signaling. It further appears that the spatial and temporal expression of NTPDases by various cell types within the vasculature, the nervous tissues and other tissues impacts on several patho-physiological processes. Examples include acute effects on cellular metabolism, adhesion, activation and migration with other protracted impacts upon developmental responses, inclusive of cellular proliferation, differentiation and apoptosis, as seen with atherosclerosis, degenerative neurological diseases and immune rejection of transplanted organs and cells. Future clinical applications are expected to involve the development of new therapeutic strategies for transplantation and various inflammatory cardiovascular, gastrointestinal and neurological diseases. © Springer Science + Business Media B.V. 2006.

引用

页码：409 / 430

页数：21

共 182 条

[11]

Abbracchio M.P., Burnstock G., Purinoceptors: Are there families of P<sub>2X</sub> and P<sub>2Y</sub> purinoceptors?, Pharmacol Ther, 64, pp. 445-475, (1994)

[12]

Dubyak G.R., El-Moatassim C., Signal transduction via P2 purinergic receptors for extracellular ATP and other nucleotides, Am J Physiol, 265, (1993)

[13]

Fredholm B.B., Abbracchio M.P., Burnstock G., Et al., Nomenclature and classification of purinoceptors, Pharmacol Rev, 46, pp. 143-156, (1994)

[14]

Palmer T.M., Stiles G.L., Adenosine receptors, Neuropharmacology, 34, pp. 683-694, (1995)

[15]

Buell G., Collo G., Rassendren F., P2X receptors: An emerging channel family, Eur J Neurosci, 8, pp. 2221-2228, (1996)

[16]

Roman R.M., Fitz J.G., Emerging roles of purinergic signalling in gastrointestinal epithelial secretion and hepatobiliary function, Gastroenterology, 116, pp. 964-979, (1999)

[17]

Plesner L., Ecto-ATPases: Identities and functions, Int Rev Cytol, 158, pp. 141-214, (1995)

[18]

Zimmermann H., Extracellular purine metabolism, Drug Dev Res, 39, pp. 337-352, (1996)

[19]

Robson S.C., Enjyoji K., Goepfert C., Et al., Modulation of extracellular nucleotide-mediated signaling by CD39/ nucleoside triphosphate diphosphohydrolase-1, Drug Dev Res, 53, pp. 193-207, (2001)

[20]

Robson S.C., Wu Y., Sun X.F., Et al., Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation, Semin Thromb Hemost, 31, pp. 217-233, (2005)

← 1 2 3 4 5 6 7 8 9 10 →